PowerShares DWA Healthcare Momentum Portfolio PTH 深 滬
已收盤 08-01 16:00:00 美东时间
37.5221
-0.272
-0.72%
華盛通- 最 高37.72
- 今 開37.39
- 成交量 8779股
- 最 低 37.12
- 昨 收 37.7939
- 總市值 9980.88万
- 52周最高 48.63
- 市盈率 靜 --
- 換手率 0.33%
- 52周最低 33.5611
- 委 比 -77.78%
- 總股本 266.00万
- 歷史最高 64.6295
- 量 比 0.89
- 振 幅 1.59%
- 歷史最低 6.9445
- 每 手 1
- 風險率 3.59%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Ascendis Pharma To Present New Data From Week 156 Of Phase 3 PaTHway Trial Demonstrating Safety And Efficacy Of Long-Term Treatment With TransCon PTH In Adults With Hypoparathyroidism, At ENDO 2025
Ascendis Pharma A/S (NASDAQ:ASND) today announced two oral presentations at ENDO 2025, the annual meeting of the Endocrine Society being held July 12-15, 2025, in San Francisco. Dr. Aliya Khan will present new data from
07-08 04:03
Why Is Channel Therapeutics Stock Surging On Friday?
Channel Therapeutics shares rise after announcing 10-for-1 reverse stock split and upcoming rebrand.
06-27 23:55
The Analyst Verdict: Septerna In The Eyes Of 4 Experts
4 analysts have shared their evaluations of Septerna (NASDAQ:SEPN) during the r...
06-23 20:02
Hims & Hers Health Sees Major Growth Opportunity In Booming Weight Loss Market, Says Analyst
Needham analyst initiates coverage on Hims & Hers Health, Inc. with a Buy rating and $24 price target. Anticipates positive impact from GLP-1 market entry and strong growth potential.
2024-08-23 02:26
